Evaluating a robotic system for coronary angioplasty procedures
Official title: Change History and Adopt a Robotic SolutioN for anGioplasty procedurE
Run by Robocath · NCT05853419 · Data updated 2026-11-12
This study is testing a new robotic system to see if it can safely help doctors perform heart procedures for patients with blocked arteries.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 120 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Robocath Industry-sponsored |
| Locations | 8 sites (Antwerp and 7 other locations) |
| Status | Recruiting |
| Started | June 20, 2023 |
| Main results expected | May 2026 |
| Study ends | June 2026 |
| Registry record updated | August 20, 2025 |
| Trial ID | NCT05853419 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with coronary artery disease who are clinically indicated for robotic-assisted PCI.
✕Probably not a fit
Patients experiencing STEMI or cardiogenic shock, or those deemed unsuitable for robotic-assisted PCI, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The CHANGE registry aims to assess the real-world performance and safety of the R-One robotic system during Percutaneous Coronary Intervention (PCI) for patients with coronary artery disease. This observational study will involve 500 patients across up to 15 centers in Europe and South Africa, utilizing the R-One system to assist in the delivery and manipulation of coronary guidewires and stent/balloon devices. The R-One system is not autonomous and operates under the direct commands of the operator, ensuring controlled intervention. The study will provide valuable data on the clinical benefits and safety profile of this innovative technology.
Why it matters
Potential benefit: If successful, this study could enhance the safety and effectiveness of PCI procedures for patients with coronary artery disease.
How similar studies have gone: While robotic-assisted PCI is a developing field, this specific approach with the R-One system is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\. Age ≥ 18 years; * 2.Subjects with coronary artery disease with clinical indication for PCI; * 3.Subject deemed appropriate for robotic-assisted PCI; and * 4.The subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent. Exclusion Criteria: * 1.Failure/inability/unwillingness to provide informed consent, unless the ethic committee has waived informed consent; or * 2.The Investigator determines that the subject or the coronary anatomy is not suitable for robotic-assisted PCI. * 3.STEMI * 4.Cardiogenic shock * 5.Subjects will not be included if they are under judicial protection, guardianship or curatorship or if they are deprived of their liberty by judicial or administrative decision.
Where it's running
-
Het Ziekenhuisnetwerk Antwerpen vzw
Antwerp, Belgium Recruiting -
Brest university hospital
Brest, Brittany Region, France Recruiting -
Rouen university hospital
Rouen, France Recruiting -
Centre Cardiologique du Nord
Saint-Denis, Île-de-France Region, France Recruiting -
Rheinland Klinikum Neuss GmbH
Neuss, Lukaskrankenhaus, Germany Recruiting -
San Donato Policlinco Kardia
San Donato Milanese, Mi, Italy Not yet recruiting
Show 2 more locations
-
Polskie Towarzystwo Kardiologiczne
Warsaw, Par Défaut, Poland Not yet recruiting -
Netcare Christiaan Barnard Memorial Hospital
Cape Town, le Cap, South Africa Not yet recruiting
Study contacts
- Principal investigator: Stefan Verheye, Prof.MD — Het Ziekenhuisnetwerk Antwerpen vzw
- Study coordinator: Hamouda Abassi, PhD
- Email: hamouda.abassi@robocath.com
- Phone: +33 2 32 10 67 42
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
Predicting how coronary artery disease progresses in adults 45 and younger
This project will try to build prediction models using coronary CT scans and health data from people aged 18–45 to see who is more likely to have plaque get worse over time.
-
Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions
This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.
-
Italian Cardiac Rehabilitation Registry for Coronary Disease and Heart Failure
This registry collects real-world information to see how cardiac rehabilitation programs work for adults recovering from coronary disease or heart failure across Italy.
-
Orbital atherectomy versus standard balloon strategy for calcified coronary bifurcation lesions
This study tests whether using orbital atherectomy before stenting helps adults with moderately or severely calcified coronary bifurcation lesions get better stent results than the standard balloon-first approach.
-
Healthy Nordic diet's effects on heart disease
This study is testing if following a Healthy Nordic diet can help people with coronary heart disease improve their heart health over 18 months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.